{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:51:54Z","timestamp":1792173114486,"version":"4.4.0"},"reference-count":194,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDD"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract:<\/jats:title>\n                    <jats:p>Despite the technological advancement in the era of personalized medicine and therapeutics\ndevelopment, infectious parasitic causative agents remain one of the most challenging areas of research\nand development. The disadvantages of conventional parasitic prevention and control are the emergence\nof multiple drug resistance as well as the non-specific targeting of intracellular parasites, which results\nin high dose concentration needs and subsequently intolerable cytotoxicity. Nanotechnology has attracted\nextensive interest to reduce medication therapy adverse effects including poor bioavailability and\ndrug selectivity. Numerous nanomaterials-based delivery systems have previously been shown in animal\nmodels to be effective in the treatment of various parasitic infections. This review discusses a variety of\nnanomaterials-based antiparasitic procedures and techniques as well as the processes that allow them to\nbe targeted to different parasitic infections. This review focuses on the key prerequisites for creating\nnovel nanotechnology-based carriers as a potential option in parasite management, specifically in the\ncontext of human-related pathogenic parasitic agents.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/1567201820666230223085403","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T06:56:47Z","timestamp":1677135407000},"page":"828-851","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nanomaterials as a Potential Target for Infectious Parasitic Agents"],"prefix":"10.2174","volume":"21","author":[{"given":"Rawan H.","family":"Alsharedeh","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid,\n21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Rezigue","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid,\n21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha M.","family":"Bashatwah","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid,\n21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneen","family":"Amawi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Faculty of Pharmacy, Yarmouk University, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9519-6338","authenticated-orcid":true,"given":"Alaa A.A.","family":"Aljabali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid,\n21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Obeid","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Yarmouk University, Irbid,\n21163, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murtaza M.","family":"Tambuwala","sequence":"additional","affiliation":[{"name":"Lincoln\nMedical School, Brayford Pool Campus, University of Lincoln, Lincoln LN6 7TS, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.addr.2007.04.009","volume":"59","author":"Date A.","year":"2007","unstructured":"Date A.; Joshi M.; Patravale V.; Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles. Adv Drug Deliv Rev  2007,59(6),505-521","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jconrel.2016.01.008","volume":"224","author":"Zazo H.","year":"2016","unstructured":"Zazo H.; Colino C.I.; Lanao J.M.; Current applications of nanoparticles in infectious diseases. J Control Release  2016,224,86-102","journal-title":"J Control Release"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"150562","DOI":"10.1016\/j.scitotenv.2021.150562","volume":"806","author":"Ma J.Y.","year":"2022","unstructured":"Ma J.Y.; Li M.Y.; Qi Z.Z.; Fu M.; Sun T.F.; Elsheikha H.M.; Cong W.; Waterborne protozoan outbreaks: An update on the global, regional, and national prevalence from 2017 to 2020 and sources of contamination. Sci Total Environ  2022,806(2),150562","journal-title":"Sci Total Environ"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.actatropica.2015.09.016","volume":"152","author":"Pensel P.E.","year":"2015","unstructured":"Pensel P.E.; Ullio Gamboa G.; Fabbri J.; Ceballos L.; Sanchez Bruni S.; Alvarez L.I.; Allemandi D.; Benoit J.P.; Palma S.D.; Elissondo M.C.; Cystic echinococcosis therapy: Albendazole-loaded lipid nanocapsules enhance the oral bioavailability and efficacy in experimentally infected mice. Acta Trop  2015,152,185-194","journal-title":"Acta Trop"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"109809","DOI":"10.1016\/j.msec.2019.109809","volume":"103","author":"Amini S.M.","year":"2019","unstructured":"Amini S.M.; Preparation of antimicrobial metallic nanoparticles with bioactive compounds. Mater Sci Eng C  2019,103,109809","journal-title":"Mater Sci Eng C"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2174\/1389201022666210202143755","volume":"22","author":"Backx B.P.","year":"2021","unstructured":"Backx B.P.; dos Santos M.S.; dos Santos O.A.L.; Filho S.A.; The role of biosynthesized silver nanoparticles in antimicrobial mechanisms. Curr Pharm Biotechnol  2021,22(6),762-772","journal-title":"Curr Pharm Biotechnol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1166\/jnn.2020.17677","volume":"20","author":"Gharpure S.","year":"2020","unstructured":"Gharpure S.; Akash A.; Ankamwar B.; A review on antimicrobial properties of metal nanoparticles. J Nanosci Nanotechnol  2020,20(6),3303-3339","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.ijpharm.2018.11.043","volume":"555","author":"Rodrigues G.R.","year":"2019","unstructured":"Rodrigues G.R.; L\u00f3pez-Abarrategui C.; de la Serna G\u00f3mez I.; Dias S.C.; Otero-Gonz\u00e1lez A.J.; Franco O.L.; Antimicrobial magnetic nanoparticles based-therapies for controlling infectious diseases. Int J Pharm  2019,555,356-367","journal-title":"Int J Pharm"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1080\/10934529.2021.1917936","volume":"56","year":"2021","unstructured":"Staro\u0144, A.; D\u0142ugosz, O. Antimicrobial properties of nanoparticles in the context of advantages and potential risks of their use. J Environ Sci Health Part A Tox Hazard Subst Environ Eng  2021,56(6),680-693","journal-title":"J Environ Sci Health Part A Tox Hazard Subst Environ Eng"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1080\/10717544.2019.1692968","volume":"26","author":"Sun Y.","year":"2019","unstructured":"Sun Y.; Chen D.; Pan Y.; Qu W.; Hao H.; Wang X.; Nanoparticles for antiparasitic drug delivery. Drug Deliv  2019,26(1),1206-1221","journal-title":"Drug Deliv"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"108008","DOI":"10.1016\/j.exppara.2020.108008","volume":"218","author":"Sharma G.","year":"2020","unstructured":"Sharma G.; Kalra S.K.; Tejan N.; Ghoshal U.; Nanoparticles based therapeutic efficacy against Acanthamoeba: Updates and future prospect. Exp Parasitol  2020,218,108008","journal-title":"Exp Parasitol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1080\/14787210.2020.1730815","volume":"18","author":"Rai M.","year":"2020","unstructured":"Rai M.; Ingle A.P.; Pandit R.; Paralikar P.; Anasane N.; Santos C.A.D.; Curcumin and curcumin-loaded nanoparticles: Antipathogenic and antiparasitic activities. Expert Rev Anti Infect Ther  2020,18(4),367-379","journal-title":"Expert Rev Anti Infect Ther"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.actatropica.2017.04.029","volume":"172","author":"Akbari M.","year":"2017","unstructured":"Akbari M.; Oryan A.; Hatam G.; Application of nanotechnology in treatment of leishmaniasis: A review. Acta Trop  2017,172,86-90","journal-title":"Acta Trop"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/molecules22081370","volume":"22","author":"Aderibigbe B.A.","year":"2017","unstructured":"Aderibigbe B.A.; Metal-based nanoparticles for the treatment of infectious diseases. Molecules  2017,22(8),1370","journal-title":"Molecules"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2174\/1389200218666170925122201","volume":"18","author":"Reshma V.G.","year":"2018","unstructured":"Reshma V.G.; Syama S.; Sruthi S.; Reshma S.C.; Remya N.S.; Mohanan P.V.; Engineered nanoparticles with antimicrobial property. Curr Drug Metab  2018,18(11),1040-1054","journal-title":"Curr Drug Metab"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2217\/fmb.11.78","volume":"6","author":"Allahverdiyev A.M.","year":"2011","unstructured":"Allahverdiyev A.M.; Abamor E.S.; Bagirova M.; Rafailovich M.; Antimicrobial effects of TiO2 and Ag2O nanoparticles against drug-resistant bacteria and leishmania parasites. Future Microbiol  2011,6(8),933-940","journal-title":"Future Microbiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"107772","DOI":"10.1016\/j.exppara.2019.107772","volume":"207","author":"Gaafar M.R.","year":"2019","unstructured":"Gaafar M.R.; El-Zawawy L.A.; El-Temsahy M.M.; Shalaby T.I.; Hassan A.Y.; Silver nanoparticles as a therapeutic agent in experimental cyclosporiasis. Exp Parasitol  2019,207,107772","journal-title":"Exp Parasitol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/1040841X.2014.912200","volume":"42","author":"Abbasi E.","year":"2014","unstructured":"Abbasi E.; Milani M.; Fekri Aval S.; Kouhi M.; Akbarzadeh A.; Tayefi Nasrabadi H.; Nikasa P.; Joo S.W.; Hanifehpour Y.; Nejati-Koshki K.; Samiei M.; Silver nanoparticles: Synthesis methods, bio-applications and properties. Crit Rev Microbiol  2014,42(2),1-8","journal-title":"Crit Rev Microbiol"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/21691401.2017.1414825","volume":"46","author":"Mathur P.","year":"2018","unstructured":"Mathur P.; Jha S.; Ramteke S.; Jain N.K.; Pharmaceutical aspects of silver nanoparticles. Artif Cells Nanomed Biotechnol  2018,46(1),115-126","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1701503","DOI":"10.1002\/adhm.201701503","volume":"7","author":"Tang S.","year":"2018","unstructured":"Tang S.; Zheng J.; Antibacterial activity of silver nanoparticles: Structural effects. Adv Healthc Mater  2018,7(13),1701503","journal-title":"Adv Healthc Mater"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"11993","DOI":"10.3390\/ijms222111993","volume":"2","author":"Jain A.S.","year":"2021","unstructured":"Jain A.S.; Pawar P.S.; Sarkar A.; Junnuthula V.; Dyawanapelly S.; Bionanofactories for green synthesis of silver nanoparticles: Toward antimicrobial applications. Int J Mol Sci  2021,2(21),11993","journal-title":"Int J Mol Sci"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3390\/ijms20040865","volume":"20","author":"Lee S.H.","year":"2019","unstructured":"Lee S.H.; Jun B.H.; Synthesis and application for nanomedicine. Int J Mol Sci  2019,20(4),865","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/lam.13082","volume":"67","author":"Tao C.","year":"2018","unstructured":"Tao C.; Antimicrobial activity and toxicity of gold nanoparticles: Research progress, challenges and prospects. Lett Appl Microbiol  2018,67(6),537-543","journal-title":"Lett Appl Microbiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.3762\/bjnano.10.195","volume":"10","author":"Aljabali A.A.A.","year":"2019","unstructured":"Aljabali A.A.A.; Zoubi M.S.A.; Al-Batanyeh K.M.; Al-Radaideh A.; Obeid M.A.; Al Sharabi A.; Alshaer W.; AbuFares B.; Al-Zanati T.; Tambuwala M.M.; Akbar N.; Evans D.J.; Gold-coated plant virus as computed tomography imaging contrast agent. Beilstein J Nanotechnol  2019,10(1),1983-1993","journal-title":"Beilstein J Nanotechnol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3390\/nano8030174","volume":"8","author":"Aljabali A.","year":"2018","unstructured":"Aljabali A.; Akkam Y.; Al Zoubi M.; Al-Batayneh K.; Al-Trad B.; Abo Alrob O.; Alkilany A.; Benamara M.; Evans D.; Synthesis of gold nanoparticles using leaf extract of Ziziphus zizyphus and their antimicrobial activity. Nanomaterials  2018,8(3),174","journal-title":"Nanomaterials"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.actatropica.2017.10.021","volume":"178","author":"Benelli G.","year":"2018","unstructured":"Benelli G.; Gold nanoparticles - against parasites and insect vectors. Acta Trop  2018,178,73-80","journal-title":"Acta Trop"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4014\/jmb.1805.05028","volume":"29","author":"Anwar A.","year":"2019","unstructured":"Anwar A.; Siddiqui R.; Shah M.; Khan N.; Gold nanoparticles conjugation enhances antiacanthamoebic properties of nystatin, fluconazole and amphotericin B. J Microbiol Biotechnol  2019,29(1),171-177","journal-title":"J Microbiol Biotechnol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"7285","DOI":"10.2147\/IJN.S268548","volume":"16","author":"Want M.Y.","year":"2021","unstructured":"Want M.Y.; Yadav P.; Khan R.; Chouhan G.; Islamuddin M.; Aloyouni S.Y.; Critical antileishmanial in vitro effects of highly examined gold nanoparticles. Int J Nanomedicine  2021,16,7285-7295","journal-title":"Int J Nanomedicine"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1166\/jnn.2021.19471","volume":"21","author":"Mart\u00ednez-Esquivias F.","year":"2021","unstructured":"Mart\u00ednez-Esquivias F.; Guzm\u00e1n-Flores J.M.; P\u00e9rez-Larios A.; Gonz\u00e1lez Silva N.; Becerra-Ruiz J.S.; A review of the antimicrobial activity of selenium nanoparticles. J Nanosci Nanotechnol  2021,21(11),5383-5398","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ijsu.2014.03.017","volume":"12","author":"Mahmoudvand H.","year":"2014","unstructured":"Mahmoudvand H.; Fasihi Harandi M.; Shakibaie M.; Aflatoonian M.R.; Zia Ali N.; Makki M.S.; Jahanbakhsh S.; Scolicidal effects of biogenic selenium nanoparticles against protoscolices of hydatid cysts. Int J Surg  2014,12(5),399-403","journal-title":"Int J Surg"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"111257","DOI":"10.1016\/j.biopha.2021.111257","volume":"136","author":"Ezzatkhah F.","year":"2021","unstructured":"Ezzatkhah F.; Khalaf A.K.; Mahmoudvand H.; Copper nanoparticles: Biosynthesis, characterization, and protoscolicidal effects alone and combined with albendazole against hydatid cyst protoscoleces. Biomed Pharmacother  2021,136,111257","journal-title":"Biomed Pharmacother"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00436-011-2387-3","volume":"109","author":"Ramyadevi J.","year":"2011","unstructured":"Ramyadevi J.; Jeyasubramanian K.; Marikani A.; Rajakumar G.; Rahuman A.A.; Santhoshkumar T.; Kirthi A.V.; Jayaseelan C.; Marimuthu S.; Copper nanoparticles synthesized by polyol process used to control hematophagous parasites. Parasitol Res  2011,109(5),1403-1415","journal-title":"Parasitol Res"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/IJN.S228538","volume":"15","author":"Norouzi R.","year":"2020","unstructured":"Norouzi R.; Ataei A.; Hejazy M.; Noreddin A.; El Zowalaty M.E.; Scolicidal effects of nanoparticles against hydatid cyst protoscolices in vitro. Int J Nanomed  2020,15,1095-1100","journal-title":"Int J Nanomed"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s00436-011-2676-x","volume":"111","author":"Velayutham K.","year":"2012","unstructured":"Velayutham K.; Rahuman A.A.; Rajakumar G.; Santhoshkumar T.; Marimuthu S.; Jayaseelan C.; Bagavan A.; Kirthi A.V.; Kamaraj C.; Zahir A.A.; Elango G.; Evaluation of Catharanthus roseus leaf extract-mediated biosynthesis of titanium dioxide nanoparticles against Hippobosca maculata and Bovicola ovis. Parasitol Res  2012,111(6),2329-2337","journal-title":"Parasitol Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"7316","DOI":"10.2174\/138161281941131219135458","volume":"19","author":"Khalil N.","year":"2013","unstructured":"Khalil N.; de Mattos A.; Moraes M.C.T.; Ludwig D.; Mainardes R.; Nanotechnological strategies for the treatment of neglected diseases. Curr Pharm Des  2013,19(41),7316-7329","journal-title":"Curr Pharm Des"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3109\/21691401.2014.953633","volume":"44","author":"Daraee H.","year":"2016","unstructured":"Daraee H.; Etemadi A.; Kouhi M.; Alimirzalu S.; Akbarzadeh A.; Application of liposomes in medicine and drug delivery. Artif Cells Nanomed Biotechnol  2016,44(1),381-391","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","volume":"27","author":"Ortega V.","year":"2017","unstructured":"Ortega V.; Giorgio S.; de Paula E.; Liposomal formulations in the pharmacological treatment of leishmaniasis: A review. J Liposome Res  2017,27(3),234-248","journal-title":"J Liposome Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1186\/s12936-021-03858-0","volume":"20","author":"Memvanga P.B.","year":"2021","unstructured":"Memvanga P.B.; Nkanga C.I.; Liposomes for malaria management: The evolution from 1980 to 2020. Malar J  2021,20(1),327","journal-title":"Malar J"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.ejmech.2019.01.007","volume":"164","author":"Li M.","year":"2019","unstructured":"Li M.; Du C.; Guo N.; Teng Y.; Meng X.; Sun H.; Li S.; Yu P.; Galons H.; Composition design and medical application of liposomes. Eur J Med Chem  2019,164,640-653","journal-title":"Eur J Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12936-022-04042-8","volume":"21","author":"Zeng S.","year":"2022","unstructured":"Zeng S.; Wang H.; Tao L.; Ning X.; Fan Y.; Zhao S.; Decoquinate liposomes: Highly effective clearance of Plasmodium parasites causing severe malaria. Malar J  2022,21(1),24","journal-title":"Malar J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","volume":"528","author":"El-Say K.M.","year":"2017","unstructured":"El-Say K.M.; El-Sawy H.S.; Polymeric nanoparticles: Promising platform for drug delivery. Int J Pharm  2017,528(1-2),675-691","journal-title":"Int J Pharm"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.3390\/molecules25163731","volume":"25","year":"2020","unstructured":"Zieli\u0144ska, A.; Carreir\u00f3, F.; Oliveira, A.M.; Neves, A.; Pires, B.; Venkatesh, D.N.; Durazzo, A.; Lucarini, M.; Eder, P.; Silva, A.M.; Santini, A.; Souto, E.B. Polymeric nanoparticles: Production, characterization, toxicology and ecotoxicology. Molecules  2020,25(16),3731","journal-title":"Molecules"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"175705","DOI":"10.1088\/1361-6528\/ab6ab9","volume":"31","author":"Durak S.","year":"2020","unstructured":"Durak S.; Arasoglu T.; Ates S.C.; Derman S.; Enhanced antibacterial and antiparasitic activity of multifunctional polymeric nanoparticles. Nanotechnology  2020,31(17),175705","journal-title":"Nanotechnology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.niox.2021.04.008","volume":"113-114","author":"Cabral F.V.","year":"2021","unstructured":"Cabral F.V.; Pelegrino M.T.; Seabra A.B.; Ribeiro M.S.; Nitric-oxide releasing chitosan nanoparticles towards effective treatment of cutaneous leishmaniasis. Nitric Oxide  2021,113-114,31-38","journal-title":"Nitric Oxide"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"454","DOI":"10.2174\/1389200218666170222145240","volume":"18","author":"Gungor S.","year":"2017","unstructured":"Gungor S.; Rezigue M.; Nanocarriers mediated topical drug delivery for psoriasis treatment. Curr Drug Metab  2017,18(5),454-468","journal-title":"Curr Drug Metab"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"587997","DOI":"10.3389\/fmolb.2020.587997","volume":"7","author":"Scioli Montoto S.","year":"2020","unstructured":"Scioli Montoto S.; Muraca G.; Ruiz M.E.; Solid lipid nanoparticles for drug delivery: Pharmacological and biopharmaceutical aspects. Front Mol Biosci  2020,7,587997","journal-title":"Front Mol Biosci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"12243","DOI":"10.1038\/s41598-020-69276-5","volume":"10","author":"Parvez S.","year":"2020","unstructured":"Parvez S.; Yadagiri G.; Gedda M.R.; Singh A.; Singh O.P.; Verma A.; Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: An effective oral combination against experimental murine visceral leishmaniasis. Sci Rep  2020,10(1),12243","journal-title":"Sci Rep"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3389\/fcimb.2020.00033","volume":"10","author":"Khosravi M.","year":"2020","unstructured":"Khosravi M.; Mohammad Rahimi H.; Doroud D.; Mirsamadi E.S.; Mirjalali H.; Zali M.R.; In vitro evaluation of mannosylated paromomycin-loaded solid lipid nanoparticles on acute toxoplasmosis. Front Cell Infect Microbiol  2020,10,33","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=49","volume":"Chapter 77","author":"Yaeger R.G.","year":"1996","unstructured":"Yaeger R.G.; Protozoa ; Protozoa: Structure, Classification, Growth, and Development. In: Baron S, editor. Medical Microbiology. 4th ed. Galveston (TX): University of Texas Medical Branch at Galveston;  1996,Chapter 77"},{"key":"ref=50","author":"Harvey R.A.","year":"2007","unstructured":"Harvey R.A.; Champe P.C.; Fisher B.F.;  Microbiology  2007","journal-title":"Microbiology"},{"key":"ref=51","author":"Markell E.K.","year":"1976","unstructured":"Markell E.K.; Voge M.;  Medical parasitology  1976","journal-title":"Medical parasitology"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/10837450.2021.1948568","volume":"26","author":"Rashidzadeh H.","year":"2021","unstructured":"Rashidzadeh H.; Tabatabaei Rezaei S.J.; Adyani S.M.; Abazari M.; Rahamooz Haghighi S.; Abdollahi H.; Ramazani A.; Recent advances in targeting malaria with nanotechnology-based drug carriers. Pharm Dev Technol  2021,26(8),807-823","journal-title":"Pharm Dev Technol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1051\/parasite\/2014059","volume":"21","author":"Sinha S.","year":"2014","unstructured":"Sinha S.; Medhi B.; Sehgal R.; Challenges of drug-resistant malaria. Parasite  2014,21,61","journal-title":"Parasite"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/1566524020666200207123253","volume":"20","author":"Tang Y.Q.","year":"2020","unstructured":"Tang Y.Q.; Ye Q.; Huang H.; Zheng W.Y.; An Overview of available antimalarials: Discovery, mode of action and drug resistance. Curr Mol Med  2020,20(8),583-592","journal-title":"Curr Mol Med"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"Conrad M.D.","year":"2019","unstructured":"Conrad M.D.; Rosenthal P.J.; Antimalarial drug resistance in Africa: The calm before the storm? Lancet Infect Dis  2019,19(10),e338-e351","journal-title":"Lancet Infect Dis"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"3601","DOI":"10.3390\/molecules24193601","volume":"24","author":"Alven S.","year":"2019","unstructured":"Alven S.; Aderibigbe B.; Combination therapy strategies for the treatment of malaria. Molecules  2019,24(19),3601","journal-title":"Molecules"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"Blasco B.","year":"2017","unstructured":"Blasco B.; Leroy D.; Fidock D.A.; Antimalarial drug resistance: Linking Plasmodium falciparum parasite biology to the clinic. Nat Med  2017,23(8),917-928","journal-title":"Nat Med"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","volume":"62","author":"Santos-Magalh\u00e3es N.S.","year":"2010","unstructured":"Santos-Magalh\u00e3es N.S.; Mosqueira V.C.F.; Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev  2010,62(4-5),560-575","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"109625","DOI":"10.1016\/j.eurpolymj.2020.109625","volume":"129","author":"Bagheri A.R.","year":"2020","unstructured":"Bagheri A.R.; Golenser J.; Greiner A.; Controlled and manageable release of antimalarial Artemisone by encapsulation in biodegradable carriers. Eur Polym J  2020,129,109625","journal-title":"Eur Polym J"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s13346-016-0290-2","volume":"6","author":"Thakkar M.S.B.","year":"2016","unstructured":"Thakkar M.S.B.; Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies. Drug Deliv Transl Res  2016,6(4),414-425","journal-title":"Drug Deliv Transl Res"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1517\/17425247.2010.534981","volume":"7","author":"Paleos C.M.","year":"2010","unstructured":"Paleos C.M.; Tsiourvas D.; Sideratou Z.; Tziveleka L.A.; Drug delivery using multifunctional dendrimers and hyperbranched polymers. Expert Opin Drug Deliv  2010,7(12),1387-1398","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/pharmaceutics10040219","volume":"10","author":"Vieira Gonzaga R.","year":"2018","unstructured":"Vieira Gonzaga R.; da Silva Santos S.; da Silva J.V.; Campos Prieto D.; Feliciano Savino D.; Giarolla J.; Targeting groups employed in selective dendrons and dendrimers. Pharmaceutics  2018,10(4),219","journal-title":"Pharmaceutics"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1017\/S0031182020000372","volume":"147","author":"Elmi T.","year":"2020","unstructured":"Elmi T.; Shafiee Ardestani M.; Hajialiani F.; Motevalian M.; Mohamadi M.; Sadeghi S.; Zamani Z.; Tabatabaie F.; Novel chloroquine loaded curcumin based anionic linear globular dendrimer G2: A metabolomics study on Plasmodium falciparum in vitro using 1HNMR spectroscopy. Parasitology  2020,147(7),747-759","journal-title":"Parasitology"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1039\/C8BM01600C","volume":"7","author":"Mart\u00ed Coma-Cros E.","year":"2019","unstructured":"Mart\u00ed Coma-Cros E.; Lancelot A.; San Anselmo M.; Neves Borgheti-Cardoso L.; Valle-Delgado J.J.; Serrano J.L.; Fern\u00e0ndez-Busquets X.; Sierra T.; Micelle carriers based on dendritic macromolecules containing bis-MPA and glycine for antimalarial drug delivery. Biomater Sci  2019,7(4),1661-1674","journal-title":"Biomater Sci"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3390\/pharmaceutics10040225","volume":"10","author":"Mart\u00ed Coma-Cros E.","year":"2018","unstructured":"Mart\u00ed Coma-Cros E.; Biosca A.; Marques J.; Carol L.; Urb\u00e1n P.; Berenguer D.; Riera M.; Delves M.; Sinden R.; Valle-Delgado J.; Spanos L.; Siden-Kiamos I.; P\u00e9rez P.; Paaijmans K.; Rottmann M.; Manfredi A.; Ferruti P.; Ranucci E.; Fern\u00e0ndez-Busquets X.; Polyamidoamine nanoparticles for the oral administration of antimalarial drugs. Pharmaceutics  2018,10(4),225","journal-title":"Pharmaceutics"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40090-018-0139-2","volume":"9","author":"Owonubi S.J.","year":"2018","unstructured":"Owonubi S.J.; Aderibigbe B.A.; Mukwevho E.; Sadiku E.R.; Ray S.S.; Characterization and in vitro release kinetics of antimalarials from whey protein-based hydrogel biocomposites. Int J Ind Chem  2018,9(1),39-52","journal-title":"Int J Ind Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1002\/jps.22191","volume":"99","author":"Dandekar P.P.","year":"2010","unstructured":"Dandekar P.P.; Jain R.; Patil S.; Dhumal R.; Tiwari D.; Sharma S.; Vanage G.; Patravale V.; Curcumin-loaded hydrogel nanoparticles: Application in anti-malarial therapy and toxicological evaluation. J Pharm Sci  2010,99(12),4992-5010","journal-title":"J Pharm Sci"},{"key":"ref=68","doi-asserted-by":"publisher","DOI":"10.1002\/app.43918","volume":"133","author":"Aderibigbe B.A.","year":"2016","unstructured":"Aderibigbe B.A.; Mhlwatika Z.; Dual release kinetics of antimalarials from soy protein isolate-carbopol-polyacrylamide based hydrogels. J Appl Polym Sci  2016,133(37)","journal-title":"J Appl Polym Sci"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cis.2013.10.014","volume":"201-202","author":"Aditya N.P.","year":"2013","unstructured":"Aditya N.P.; Vathsala P.G.; Vieira V.; Murthy R.S.R.; Souto E.B.; Advances in nanomedicines for malaria treatment. Adv Colloid Interface Sci  2013,201-202,1-17","journal-title":"Adv Colloid Interface Sci"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01796-15","volume":"60","author":"Rajendran V.","year":"2013","unstructured":"Rajendran V.; Rohra S.; Raza M.; Hasan G.M.; Dutt S.; Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria. Antimicrob Agents Chemother  2013,60(3),1304-1318","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1186\/1556-276X-6-620","volume":"6","author":"Urb\u00e1n P.","year":"2011","unstructured":"Urb\u00e1n P.; Estelrich J.; Adeva A.; Cort\u00e9s A.; Fern\u00e0ndez-Busquets X.; Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors. Nanoscale Res Lett  2011,6(1),620","journal-title":"Nanoscale Res Lett"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"e251671","DOI":"10.1590\/1519-6984.251671","volume":"83","author":"Algehani A.","year":"2021","unstructured":"Algehani A.; Jaber F.; Khan A.; Alsulami M.N.; Review on trypanosomiasis and their prevalence in some country on the Red Sea. Braz J Biol  2021,83,e251671","journal-title":"Braz J Biol"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","volume":"375","author":"Brun R.","year":"2010","unstructured":"Brun R.; Blum J.; Chappuis F.; Burri C.; Human African trypanosomiasis. Lancet  2010,375(9709),148-159","journal-title":"Lancet"},{"key":"ref=74","first-page":"369","volume":"62","author":"Apted F.I.","year":"1965","unstructured":"Apted F.I.; Trypanosomiasis African trypanosomiasis: Human. Trop Dis Bull  1965,62,369-383","journal-title":"Trop Dis Bull"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"601151","DOI":"10.3389\/fchem.2020.601151","volume":"8","author":"Muraca G.","year":"2020","unstructured":"Muraca G.; Berti I.R.; Sbaraglini M.L.; F\u00e1varo W.J.; Dur\u00e1n N.; Castro G.R.; Talevi A.; Trypanosomatid-caused conditions: State of the art of therapeutics and potential applications of lipid-based nanocarriers. Front Chem  2020,8,601151","journal-title":"Front Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","volume":"152","author":"Barrett M.P.","year":"2007","unstructured":"Barrett M.P.; Boykin D.W.; Brun R.; Tidwell, RR Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease. Br J Pharmacol  2007,152(8),1155-1171","journal-title":"Br J Pharmacol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"4064","DOI":"10.1128\/AAC.02605-14","volume":"58","author":"Yang S.","year":"2014","unstructured":"Yang S.; Wenzler T.; Miller P.N.; Wu H.; Boykin D.W.; Brun R.; Pharmacokinetic comparison to determine the mechanisms underlying the differential efficacies of cationic diamidines against first- and second-stage human African trypanosomiasis. Antimicrob Agents Chemother  2014,58(7),4064-4074","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"11305","DOI":"10.1021\/cr500365f","volume":"114","author":"Nagle A.S.","year":"2014","unstructured":"Nagle A.S.; Khare S.; Kumar A.B.; Supek F.; Buchynskyy A.; Mathison C.J.; Recent developments in drug discovery for leishmaniasis and human African trypanosomiasis. Chem Rev  2014,114(22),11305-11347","journal-title":"Chem Rev"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1080\/21691401.2019.1596923","volume":"47","author":"Omarch G.","year":"2019","unstructured":"Omarch G.; Kippie Y.; Mentor S.; Ebrahim N.; Fisher D.; Murilla G.; Swai H.; Dube A.; Comparative in vitro transportation of pentamidine across the blood-brain barrier using polycaprolactone nanoparticles and phosphatidylcholine liposomes. Artif Cells Nanomed Biotechnol  2019,47(1),1428-1436","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"105080","DOI":"10.1016\/j.actatropica.2019.105080","volume":"198","author":"Arr\u00faa E.C.","year":"2019","unstructured":"Arr\u00faa E.C.; Seremeta K.P.; Bedogni G.R.; Okulik N.B.; Salomon C.J.; Nanocarriers for effective delivery of benznidazole and nifurtimox in the treatment of chagas disease: A review. Acta Trop  2019,198,105080","journal-title":"Acta Trop"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0065-308X(05)61004-4","volume":"61","author":"Yamagata Y.","year":"2006","unstructured":"Yamagata Y.; Nakagawa J.; Control of Chagas disease. Adv Parasitol  2006,61,129-165","journal-title":"Adv Parasitol"},{"key":"ref=82","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/489758","author":"Rodr\u00edguez-Morales O.","year":"2015","unstructured":"Rodr\u00edguez-Morales O.; Monte\u00f3n-Padilla V.; Carrillo-S\u00e1nchez S.C.; Rios-Castro M.; Mart\u00ednez-Cruz M.; Carabarin-Lima A.; Ex perimental vaccines against Chagas disease: A journey through history. J Immunol Res 2015  2015","journal-title":"J Immunol Res 2015"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1086\/656917","volume":"51","author":"Jackson Y.","year":"2010","unstructured":"Jackson Y.; Alirol E.; Getaz L.; Wolff H.; Combescure C.; Chappuis F.; Tolerance and safety of nifurtimox in patients with chronic chagas disease. Clin Infect Dis  2010,51(10),e69-e75","journal-title":"Clin Infect Dis"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1056\/NEJMct1014204","volume":"364","author":"Bern C.","year":"2011","unstructured":"Bern C.; Antitrypanosomal therapy for chronic Chagas\u2019 disease. N Engl J Med  2011,364(26),2527-2534","journal-title":"N Engl J Med"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.2042-7158.1998.tb03301.x","volume":"50","author":"Gonzalez-Martin G.","year":"2011","unstructured":"Gonzalez-Martin G.; Merino I.; Rodriguez-Cabezas M.N.; Torres M.; Nu\u00e1ez R.; Osuna A.; Characterization and trypanocidal activity of nifurtimox-containing and empty nanoparticles of polyethylcyanoacrylates. J Pharm Pharmacol  2011,50(1),29-35","journal-title":"J Pharm Pharmacol"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4269\/ajtmh.15-0889","volume":"95","author":"Scalise M.L.","year":"2016","unstructured":"Scalise M.L.; Arrua E.C.; Rial M.S.; Esteva M.I.; Salomon C.J.; Fichera L.E.; Promising efficacy of benznidazole nanoparticles in acute Trypanosoma cruzi murine model: In vitro and in vivo studies. Am J Trop Med Hyg  2016,95(2),388-393","journal-title":"Am J Trop Med Hyg"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"e1216","DOI":"10.1371\/journal.pntd.0001216","volume":"5","author":"Cencig S.","year":"2011","unstructured":"Cencig S.; Coltel N.; Truyens C.; Carlier Y.; Parasitic loads in tissues of mice infected with Trypanosoma cruzi and treated with AmBisome. PLoS Negl Trop Dis  2011,5(6),e1216","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s10123-021-00201-0","volume":"25","author":"Mungroo M.R.","year":"2021","unstructured":"Mungroo M.R.; Khan N.A.; Anwar A.; Siddiqui R.; Nanovehicles in the improved treatment of infections due to brain-eating amoebae. Int Microbiol  2021,25(2),225-235","journal-title":"Int Microbiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.actatropica.2020.105618","volume":"211","author":"Walvekar S.","year":"2020","unstructured":"Walvekar S.; Anwar A.; Anwar A.; Sridewi N.; Khalid M.; Yow Y.Y.; Khan N.A.; Anti-amoebic potential of azole scaffolds and nanoparticles against pathogenic Acanthamoeba. Acta Trop  2020,211,105618","journal-title":"Acta Trop"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"107915","DOI":"10.1016\/j.exppara.2020.107915","volume":"215","author":"Anwar A.","year":"2020","unstructured":"Anwar A.; Soomaroo A.; Anwar A.; Siddiqui R.; Khan N.A.; Metformin-coated silver nanoparticles exhibit anti-acanthamoebic activities against both trophozoite and cyst stages. Exp Parasitol  2020,215,107915","journal-title":"Exp Parasitol"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1007\/s00436-018-6049-6","volume":"117","author":"Padzik M.","year":"2018","unstructured":"Padzik M.; Hendiger E.B.; Chomicz L.; Grodzik M.; Szmidt M.; Grobelny J.; Lorenzo-Morales J.; Tannic acid-modified silver nanoparticles as a novel therapeutic agent against Acanthamoeba. Parasitol Res  2018,117(11),3519-3525","journal-title":"Parasitol Res"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00436-012-2866-1","volume":"111","author":"Said D.","year":"2012","unstructured":"Said D.; Elsamad L.; Gohar Y.M.; Validity of silver, chitosan, and curcumin nanoparticles as anti-Giardia agents. Parasitol Res  2012,111(2),545-554","journal-title":"Parasitol Res"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s12639-021-01371-4","volume":"45","author":"Al-Ardi M.H.","year":"2021","unstructured":"Al-Ardi M.H.; Anti-parasitic activity of nano Citrullus colocynthis and nano Capparis spinose against Trichomonas vaginalis in vitro. J Parasit Dis  2021,45(3),845-850","journal-title":"J Parasit Dis"},{"key":"ref=94","first-page":"27","volume":"16","author":"Bavand Z.","year":"2014","unstructured":"Bavand Z.; Gholami S.; Honari S.; Rahimi Esboei B.; Torabi N.; Effect of gold nanoparticles on giardia lamblia cyst stage in in vitro. J Arak Univ Med Sci  2014,16(10),27-37","journal-title":"J Arak Univ Med Sci"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s11274-021-03000-x","volume":"37","author":"Jafarpour Azami S.","year":"2021","unstructured":"Jafarpour Azami S.; Mohammad Rahimi H.; Mirjalali H.; Zali M.R.; Unravelling Toxoplasma treatment: Conventional drugs toward nanomedicine. World J Microbiol Biotechnol  2021,37(3),48","journal-title":"World J Microbiol Biotechnol"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.3389\/fpsyt.2019.01012","volume":"10","author":"Flegr J.","year":"2019","unstructured":"Flegr J.; Horacek J.; Negative effects of latent toxoplasmosis on mental health. Front Psychiatry  2019,10,1012","journal-title":"Front Psychiatry"},{"key":"ref=97","first-page":"940","author":"Webster J.P.","year":"2010","unstructured":"Webster J.P.; Dubey J.P.;  Parasites and Vectors  2010,940","journal-title":"Parasites and Vectors"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fcimb.2019.00185","author":"Melchor S.J.","year":"2019","unstructured":"Melchor S.J.; Ewald S.E.; Disease tolerance in toxoplasma infection. Front Cell Infect Microbiol  2019,185","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/9781555817381.ch138","author":"Mcauley J.B.","year":"2015","unstructured":"Mcauley J.B.; Jones J.L.; Singh K.;  Manual of Clinical Microbiology  2015,2373-2386","journal-title":"Manual of Clinical Microbiology"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.exppara.2014.12.007","volume":"149","author":"El-Zawawy L.A.","year":"2015","unstructured":"El-Zawawy L.A.; El-Said D.; Mossallam S.F.; Ramadan H.S.; Younis S.S.; Triclosan and triclosan-loaded liposomal nanoparticles in the treatment of acute experimental toxoplasmosis. Exp Parasitol  2015,149,54-64","journal-title":"Exp Parasitol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.exppara.2014.05.005","volume":"143","author":"Gaafar M.R.","year":"2014","unstructured":"Gaafar M.R.; Mady R.F.; Diab R.G.; Shalaby T.I.; Chitosan and silver nanoparticles: Promising anti-toxoplasma agents. Exp Parasitol  2014,143,30-38","journal-title":"Exp Parasitol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"106156","DOI":"10.1016\/j.actatropica.2021.106156","volume":"224","author":"Ebrahimi M.","year":"2021","unstructured":"Ebrahimi M.; Montazeri M.; Ahmadi A.; Nami S.; Hamishehkar H.; Shahrivar F.; Bakhtiar N.M.; Nissapatorn V.; Spotin A.; Ahmadpour E.; Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole. Acta Trop  2021,224,106156","journal-title":"Acta Trop"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11686-020-00255-6","volume":"66","author":"Elmi T.","year":"2021","unstructured":"Elmi T.; Rahimi Esboei B.; Sadeghi F.; Zamani Z.; Didehdar M.; Fakhar M.; Chabra A.; Hajialiani F.; Namazi M.J.; Tabatabaie F.; In vitro antiprotozoal effects of nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis. Acta Parasitol  2021,66(1),39-52","journal-title":"Acta Parasitol"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21608\/puj.2021.55537.1102","volume":"14","author":"Fahmy A.","year":"2021","unstructured":"Fahmy A.; Fahmy Z.; Aly E.; Elshenawy A.; El- Wakil, E. Therapeutic potential of Commiphora molmol extract loaded on chitosan nanofibers against experimental cryptosporidiosis. Parasitol United J  2021,14(1),39-45","journal-title":"Parasitol United J"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1007\/s00436-019-06364-0","volume":"118","author":"Ahmed S.A.","year":"2019","unstructured":"Ahmed S.A.; El-Mahallawy H.S.; Karanis P.; Inhibitory activity of chitosan nanoparticles against Cryptosporidium parvum oocysts. Parasitol Res  2019,118(7),2053-2063","journal-title":"Parasitol Res"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"105698","DOI":"10.1016\/j.mimet.2019.105698","volume":"165","author":"Hassan D.","year":"2019","unstructured":"Hassan D.; Farghali M.; Eldeek H.; Gaber M.; Elossily N.; Ismail T.; Antiprotozoal activity of silver nanoparticles against Cryptosporidium parvum oocysts: New insights on their feasibility as a water disinfectant. J Microbiol Methods  2019,165,105698","journal-title":"J Microbiol Methods"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/nano9121749","volume":"9","author":"Saleem K.","year":"2019","unstructured":"Saleem K.; Khursheed Z.; Hano C.; Anjum I.; Anjum S.; Applications of nanomaterials in Leishmaniasis: A focus on recent advances and challenges. Nanomaterials  2019,9(12),1749","journal-title":"Nanomaterials"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"120761","DOI":"10.1016\/j.ijpharm.2021.120761","volume":"605","author":"Kammona O.","year":"2021","unstructured":"Kammona O.; Tsanaktsidou E.; Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis. Int J Pharm  2021,605,120761","journal-title":"Int J Pharm"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4314\/ajcem.v13i2.6","volume":"13","author":"Igbineweka O.O.","year":"2012","unstructured":"Igbineweka O.O.; Aghedo F.I.; Idusuyi O.; Hussain N.A.; Microbiology E.; Evaluating the efficacy of topical silver nitrate and intramuscular antimonial drugs in the treatment of cutaneous leishmaniasis in sokoto, Nigeria. Afr J Clin Exp Microbiol  2012,13(2),90-97","journal-title":"Afr J Clin Exp Microbiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0974-777X.62887","volume":"2","author":"Chakravarty J.","year":"2010","unstructured":"Chakravarty J.; Sundar S.; Drug resistance in leishmaniasis. J Glob Infect Dis  2010,2(2),167-176","journal-title":"J Glob Infect Dis"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/cid\/cis474","volume":"55","author":"Sundar S.","year":"2012","unstructured":"Sundar S.; Singh A.; Rai M.; Prajapati V.K.; Singh A.K.; Ostyn B.; Boelaert M.; Dujardin J.C.; Chakravarty J.; Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis  2012,55(4),543-550","journal-title":"Clin Infect Dis"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.2217\/nnm-2016-0265","volume":"11","author":"Karamanidou T.","year":"2016","unstructured":"Karamanidou T.; Bourganis V.; Kammona O.; Kiparissides C.; Lipid-based nanocarriers for the oral administration of biopharmaceutics. Nanomedicine  2016,11(22),3009-3032","journal-title":"Nanomedicine"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"e818","DOI":"10.1371\/journal.pntd.0000818","volume":"4","author":"Meheus F.","year":"2010","unstructured":"Meheus F.; Balasegaram M.; Olliaro P.; Sundar S.; Rijal S.; Faiz M.A.; Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis  2010,4(9),e818","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.3390\/ijms13022405","volume":"13","author":"S\u00e1nchez-Moreno P.","year":"2012","unstructured":"S\u00e1nchez-Moreno P.; Ortega-Vinuesa J.L.; Mart\u00edn-Rodr\u00edguez A.; Boulaiz H.; Marchal-Corrales J.A.; Peula-Garc\u00eda J.M.; Characterization of different functionalized lipidic nanocapsules as potential drug carriers. Int J Mol Sci  2012,13(2),2405-2424","journal-title":"Int J Mol Sci"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.ijpharm.2011.08.016","volume":"420","author":"Van de Ven H.","year":"2011","unstructured":"Van de Ven H.; Vermeersch M.; Matheeussen A.; Vandervoort J.; Weyenberg W.; Apers S.; Cos P.; Maes L.; Ludwig A.; PLGA nanoparticles loaded with the antileishmanial saponin \u03b2-aescin: Factor influence study and in vitro efficacy evaluation. Int J Pharm  2011,420(1),122-132","journal-title":"Int J Pharm"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1128\/AAC.01984-12","volume":"57","author":"Asthana S.","year":"2013","unstructured":"Asthana S.; Jaiswal A.K.; Gupta P.K.; Pawar V.K.; Dube A.; Chourasia M.K.; Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules. Antimicrob Agents Chemother  2013,57(4),1714-1722","journal-title":"Antimicrob Agents Chemother"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/scipharm85040036","volume":"85","author":"Khatami M.","year":"2017","unstructured":"Khatami M.; Alijani H.; Sharifi I.; Sharifi F.; Pourseyedi S.; Kharazi S.; eishmanicidal activity of biogenic Fe3O4 nanoparticles. Sci Pharm  2017,85(4),36-22","journal-title":"Sci Pharm"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.jtemb.2012.11.002","volume":"27","author":"Beheshti N.","year":"2013","unstructured":"Beheshti N.; Soflaei S.; Shakibaie M.; Yazdi M.H.; Ghaffarifar F.; Dalimi A.; Shahverdi A.R.; Efficacy of biogenic selenium nanoparticles against Leishmania major: In vitro and in vivo studies. J Trace Elem Med Biol  2013,27(3),203-207","journal-title":"J Trace Elem Med Biol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.tiv.2013.06.002","volume":"27","author":"Jebali A.","year":"2013","unstructured":"Jebali A.; Kazemi B.; Nano-based antileishmanial agents: A toxicological study on nanoparticles for future treatment of cutaneous leishmaniasis. Toxicol In vitro  2013,27(6),1896-1904","journal-title":"Toxicol In vitro"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2217\/nnm.14.116","volume":"10","author":"Barros D.","year":"2015","unstructured":"Barros D.; Costa Lima S.A.; Cordeiro-da-Silva A.; Surface functionalization of polymeric nanospheres modulates macrophage activation: Relevance in Leishmaniasis therapy. Nanomedicine  2015,10(3),387-403","journal-title":"Nanomedicine"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/jac\/dkr002","volume":"66","author":"Prajapati V.K.","year":"2011","unstructured":"Prajapati V.K.; Awasthi K.; Gautam S.; Yadav T.P.; Rai M.; Srivastava O.N.; Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes. J Antimicrob Chemother  2011,66(4),874-879","journal-title":"J Antimicrob Chemother"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1172\/JCI34261","volume":"118","author":"Hotez P.J.","year":"2008","unstructured":"Hotez P.J.; Brindley P.J.; Bethony J.M.; King C.H.; Pearce E.J.; Jacobson J.; Helminth infections: The great neglected tropical diseases. J Clin Invest  2008,118(4),1311-1321","journal-title":"J Clin Invest"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"20211878","DOI":"10.1098\/rspb.2021.1878","volume":"289","author":"Phillips J.A.","year":"2022","unstructured":"Phillips J.A.; Vargas S.J.S.; Pawar S; Koprivnikar J; Benesh DP; Molnar PK; The effects of phylogeny, habitat and host characteristics on the thermal sensitivity of helminth development. Proc Biol Sci  2022,289(1968),20211878","journal-title":"Proc Biol Sci"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.pt.2022.01.007","volume":"38","author":"Whitehead B.","year":"2022","unstructured":"Whitehead B.; Christiansen S.; Ostergaard L.; Nejsum P.; Helminths and COVID-19 susceptibility, disease progression, and vaccination efficacy. Trends Parasitol  2022,38(4),277-279","journal-title":"Trends Parasitol"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s00436-022-07463-1","volume":"121","author":"Lombardo J.F.","year":"2022","unstructured":"Lombardo J.F.; P\u00f3rfido J.L.; Sisti M.S.; Giorello A.N.; Rodr\u00edguez S.; C\u00f3rsico B.; Franchini G.R.; Function of lipid binding proteins of parasitic helminths: Still a long road. Parasitol Res  2022,121(4),1117-1129","journal-title":"Parasitol Res"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1111\/jfd.13526","volume":"44","author":"Scholz T.","year":"2021","unstructured":"Scholz T.; Kuchta R.; Oros M.; Tapeworms as pathogens of fish: A review. J Fish Dis  2021,44(12),1883-1900","journal-title":"J Fish Dis"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/11795476211072670","author":"Bhandari R.","year":"2022","unstructured":"Bhandari R.; Chamlagain R.; Sutanto E.; Adam H.; Dhungana A.; Ali A.A.; Piya B.; Ubaid A.; Neumayr A.; Intestinal perforation due to adult tapeworm of Taenia: A case report and review of the literature. Clin Med Insights Case Rep  2022,15","journal-title":"Clin Med Insights Case Rep"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1007\/s00436-021-07281-x","volume":"120","author":"Aranda-L\u00f3pez Y.","year":"2021","unstructured":"Aranda-L\u00f3pez Y.; L\u00f3pez-L\u00f3pez L.; Castro K.E.N.; Ponce-Regalado M.D.; Becerril-Villanueva L.E.; Gir\u00f3n-P\u00e9rez M.I.; Del R\u00edo-Araiza V.H.; Morales-Montor J.; Cysticidal effect of a pure naphthoquinone on Taenia crassiceps cysticerci. Parasitol Res  2021,120(11),3783-3794","journal-title":"Parasitol Res"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1002\/dc.24957","volume":"50","author":"Goyal S.","year":"2022","unstructured":"Goyal S.; Goyal S.; Cysticercosis: A case of missed diagnosis. Diagn Cytopathol  2022,50(8),E214-E216","journal-title":"Diagn Cytopathol"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s13346-018-0576-7","volume":"8","author":"Silva L.D.","year":"2018","unstructured":"Silva L.D.; Lima N.F.; Arrua E.C.; Salomon C.J.; Vinaud M.C.; Research T.; In vivo treatment of experimental neurocysticercosis with praziquantel nanosuspensions - a metabolic approach. Drug Deliv Transl Res  2018,8(5),1265-1273","journal-title":"Drug Deliv Transl Res"},{"key":"ref=131","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vetpar.2017.12.022","volume":"251","author":"Pensel P.","year":"2018","unstructured":"Pensel P.; Paredes A.; Albani C.M.; Allemandi D.; Sanchez Bruni S.; Palma S.D.; Elissondo M.C.; Albendazole nanocrystals in experimental alveolar echinococcosis: Enhanced chemoprophylactic and clinical efficacy in infected mice. Vet Parasitol  2018,251,78-84","journal-title":"Vet Parasitol"},{"key":"ref=132","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1017\/S0031182019001057","volume":"146","author":"Fabbri J.","year":"2019","unstructured":"Fabbri J.; Pensel P.E.; Albani C.M.; Arce V.B.; M\u00e1rtire D.O.; Elissondo M.C.; Drug repurposing for the treatment of alveolar echinococcosis: In vitro and in vivo effects of silica nanoparticles modified with dichlorophen. Parasitology  2019,146(13),1620-1630","journal-title":"Parasitology"},{"key":"ref=133","doi-asserted-by":"publisher","first-page":"203","DOI":"10.17420\/ap6702.330","volume":"67","author":"Fateh R.","year":"2021","unstructured":"Fateh R.; Norouzi R.; Mirzaei E.; Nissapatron V.; Nawaz M.; Khalifeh-Gholi M.; Hamta A.; Adnani Sadati S.J.; Siyadatpanah A.; Fattahi Bafghi A.; In vitro evaluation of albendazole nanocrystals against Echinococcus granulosus protoscolices. Ann Parasitol  2021,67(2),203-212","journal-title":"Ann Parasitol"},{"key":"ref=134","doi-asserted-by":"publisher","first-page":"e0261166","DOI":"10.1371\/journal.pone.0261166","volume":"16","author":"Dermauw V.","year":"2021","unstructured":"Dermauw V.; Muchai J.; Al Kappany Y.; Fajardo Castaneda A.L.; Dorny, P Human fascioliasis in Africa: A systematic review. PLoS One  2021,16(12),e0261166","journal-title":"PLoS One"},{"key":"ref=135","doi-asserted-by":"publisher","first-page":"e0207625","DOI":"10.1371\/journal.pone.0207625","volume":"13","author":"Real D.","year":"2018","unstructured":"Real D.; Hoffmann S.; Leonardi D.; Salomon C.; Goycoolea F.M.; Chitosan-based nanodelivery systems applied to the development of novel triclabendazole formulations. PLoS One  2018,13(12),e0207625","journal-title":"PLoS One"},{"key":"ref=136","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.drudis.2019.12.007","volume":"25","year":"2020","unstructured":"Zaj\u00ed\u010dkov\u00e1, M.; Nguyen, L.T.; Sk\u00e1lov\u00e1, L.; Raisov\u00e1 Stuchl\u00edkov\u00e1, L.; Matou\u0161kov\u00e1, P. Anthelmintics in the future: Current trends in the discovery and development of new drugs against gastrointestinal nematodes. Drug Discov Today  2020,25(2),430-437","journal-title":"Drug Discov Today"},{"key":"ref=137","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s13071-021-04953-6","volume":"14","author":"Vlaar L.E.","year":"2021","unstructured":"Vlaar L.E.; Bertran A.; Rahimi M.; Dong L.; Kammenga J.E.; Helder J.; On the role of dauer in the adaptation of nematodes to a parasitic lifestyle. Parasit Vectors  2021,14(1),554","journal-title":"Parasit Vectors"},{"key":"ref=138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1756-3305-6-153","volume":"6","author":"Roeber F.","year":"2013","unstructured":"Roeber F.; Jex A.R.; Gasser R.B.; Impact of gastrointestinal parasitic nematodes of sheep, and the role of advanced molecular tools for exploring epidemiology and drug resistance - an Australian perspective. Parasit Vectors  2013,6(1),153","journal-title":"Parasit Vectors"},{"key":"ref=139","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pt.2010.06.002","volume":"26","author":"Payne L.","year":"2010","unstructured":"Payne L.; Fitchett J.R.; Bringing neglected tropical diseases into the spotlight. Trends Parasitol  2010,26(9),421-423","journal-title":"Trends Parasitol"},{"key":"ref=140","doi-asserted-by":"publisher","first-page":"110570","DOI":"10.1016\/j.ecoenv.2020.110570","volume":"197","author":"Ayech A.","year":"2020","unstructured":"Ayech A.; Josende M.E.; Ventura-Lima J.; Ruas C.; Gelesky M.A.; Ale A.; Cazenave J.; Galdop\u00f3rpora J.M.; Desimone M.F.; Duarte M.; Halicki P.; Ramos D.; Carvalho L.M.; Leal G.C.; Monserrat J.M.; Toxicity evaluation of nanocrystalline silver-impregnated coated dressing on the life cycle of worm Caenorhabditis elegans. Ecotoxicol Environ Saf  2020,197,110570","journal-title":"Ecotoxicol Environ Saf"},{"key":"ref=141","doi-asserted-by":"publisher","first-page":"5093","DOI":"10.2147\/IJN.S84909","volume":"10","author":"Char\u00e3o M.F.","year":"2015","unstructured":"Char\u00e3o M.F.; Souto C.; Brucker N.; Barth A.; Jornada D.S.; Fagundez D.; \u00c1vila D.S.; Eifler-Lima V.L.; Guterres S.S.; Pohlmann A.R.; Garcia S.C.; Caenorhabditis elegans as an alternative in vivo model to determine oral uptake, nanotoxicity, and efficacy of melatonin-loaded lipid-core nanocapsules on paraquat damage. Int J Nanomedicine  2015,10,5093-5106","journal-title":"Int J Nanomedicine"},{"key":"ref=142","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1166\/jnn.2020.17364","volume":"20","author":"Chen L.","year":"2020","unstructured":"Chen L.; Li J.; Chen Z.; Gu Z.; Yan L.; Zhao F.; Zhang A.; Toxicological evaluation of graphene-family nanomaterials. J Nanosci Nanotechnol  2020,20(4),1993-2006","journal-title":"J Nanosci Nanotechnol"},{"key":"ref=143","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.chemosphere.2019.01.021","volume":"221","author":"Wu T.","year":"2019","unstructured":"Wu T.; Xu H.; Liang X.; Tang M.; Caenorhabditis elegans as a complete model organism for biosafety assessments of nanoparticles. Chemosphere  2019,221,708-726","journal-title":"Chemosphere"},{"key":"ref=144","doi-asserted-by":"publisher","first-page":"130421","DOI":"10.1016\/j.chemosphere.2021.130421","volume":"278","author":"Bortolozzo L.S.","year":"2021","unstructured":"Bortolozzo L.S.; C\u00f4a F.; Khan L.U.; Medeiros A.M.Z.; Da Silva G.H.; Delite F.S.; Strauss M.; Martinez D.S.T.; Mitigation of graphene oxide toxicity in C. elegans after chemical degradation with sodium hypochlorite. Chemosphere  2021,278,130421","journal-title":"Chemosphere"},{"key":"ref=145","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.chemosphere.2016.11.011","volume":"168","author":"Luo X.","year":"2017","unstructured":"Luo X.; Xu S.; Yang Y.; Zhang Y.; Wang S.; Chen S.; Xu A.; Wu L.; A novel method for assessing the toxicity of silver nanoparticles in Caenorhabditis elegans. Chemosphere  2017,168,648-657","journal-title":"Chemosphere"},{"key":"ref=146","doi-asserted-by":"publisher","first-page":"9903","DOI":"10.1002\/anie.201504987","volume":"54","author":"Miyako E.","year":"2015","unstructured":"Miyako E.; Chechetka S.A.; Doi M.; Yuba E.; Kono K.; In vivo remote control of reactions in Caenorhabditis elegans by using supramolecular nanohybrids of carbon nanotubes and liposomes. Angew Chem Int Ed  2015,54(34),9903-9906","journal-title":"Angew Chem Int Ed"},{"key":"ref=147","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s12026-017-8911-5","volume":"65","author":"Immanuel C.","year":"2017","unstructured":"Immanuel C.; Ramanathan A.; Balasubramaniyan M.; Khatri V.K.; Amdare N.P.; Rao D.N.; Reddy M.V.R.; Perumal K.; Immunoprophylaxis of multi-antigen peptide (MAP) vaccine for human lymphatic filariasis. Immunol Res  2017,65(3),729-738","journal-title":"Immunol Res"},{"key":"ref=148","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1517\/17425247.2013.771630","volume":"10","author":"Ali M.","year":"2013","unstructured":"Ali M.; Afzal M.; Bhattacharya S.M.; Ahmad F.J.; Dinda A.K.; Nanopharmaceuticals to target antifilarials: A comprehensive review. Expert Opin Drug Deliv  2013,10(5),665-678","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=149","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.colsurfb.2017.10.057","volume":"161","author":"Roy P.","year":"2018","unstructured":"Roy P.; Saha S.K.; Gayen P.; Chowdhury P.; Sinha Babu S.P.; Exploration of antifilarial activity of gold nanoparticle against human and bovine filarial parasites: A nanomedicinal mechanistic approach. Colloids Surf B Biointerfaces  2018,161,236-243","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=150","doi-asserted-by":"publisher","first-page":"e0009908","DOI":"10.1371\/journal.pntd.0009908","volume":"15","author":"Chapman P.R.","year":"2021","unstructured":"Chapman P.R.; Giacomin P.; Loukas A.; McCarthy J.S.; Experimental human hookworm infection: A narrative historical review. PLoS Negl Trop Dis  2021,15(12),e0009908","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=151","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1093\/infdis\/jiz528","volume":"221","author":"Bartlett S.","year":"2020","unstructured":"Bartlett S.; Eichenberger R.M.; Nevagi R.J.; Ghaffar K.A.; Marasini N.; Dai Y.; Loukas A.; Toth I.; Skwarczynski M.; Lipopeptide-based oral vaccine against hookworm infection. J Infect Dis  2020,221(6),934-942","journal-title":"J Infect Dis"},{"key":"ref=152","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.3390\/vaccines9091034","volume":"9","author":"Shalash A.O.","year":"2021","unstructured":"Shalash A.O.; Becker L.; Yang J.; Giacomin P.; Pearson M.; Hussein W.M.; Oral peptide vaccine against hookworm infection: Correlation of antibody titers with protective efficacy. Vaccines  2021,9(9),1034","journal-title":"Vaccines"},{"key":"ref=153","doi-asserted-by":"publisher","first-page":"5521","DOI":"10.3390\/jcm10235521","volume":"10","author":"Carbonell C.","year":"2021","unstructured":"Carbonell C.; Rodriguez-Alonso B.; Lopez-Bernus A.; Almeida H.; Galindo-Perez I.; Velasco-Tirado V.; Clinical spectrum of schistosomiasis: An update. J Clin Med  2021,10(23),5521","journal-title":"J Clin Med"},{"key":"ref=154","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2174\/1871526519666181231153139","volume":"19","author":"Aruleba R.T.","year":"2019","unstructured":"Aruleba R.T.; Adekiya T.A.; Oyinloye B.E.; Masamba P.; Mbatha L.S.; Pretorius A.; Kappo A.P.; PZQ therapy: How close are we in the development of effective alternative anti-schistosomal drugs? Infect Disord Drug Targets  2019,19(4),337-349","journal-title":"Infect Disord Drug Targets"},{"key":"ref=155","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.actatropica.2017.06.025","volume":"174","author":"Tomiotto-Pellissier F.","year":"2017","unstructured":"Tomiotto-Pellissier F.; Miranda-Sapla M.M.; Machado L.F.; Bortoleti B.T.S.; Sahd C.S.; Chagas A.F.; Assolini J.P.; Oliveira F.J.A.; Pavanelli W.R.; Conchon-Costa I.; Costa I.N.; Melanda F.N.; Nanotechnology as a potential therapeutic alternative for schistosomiasis. Acta Trop  2017,174,64-71","journal-title":"Acta Trop"},{"key":"ref=156","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s12639-019-01106-6","volume":"43","author":"Labib El Gendy A.E.M.","year":"2019","unstructured":"Labib El Gendy A.E.M.; Mohammed F.A.; Abdel-Rahman S.A.; Shalaby T.I.A.; Fathy G.M.; Mohammad S.M.; Effect of nanoparticles on the therapeutic efficacy of praziquantel against Schistosoma mansoni infection in murine models. J Parasit Dis  2019,43(3),416-425","journal-title":"J Parasit Dis"},{"key":"ref=157","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.actatropica.2015.07.022","volume":"150","author":"Frezza T.F.","year":"2015","unstructured":"Frezza T.F.; de Souza A.L.R.; Ribeiro Prado C.C.; de Oliveira C.N.F.; Gremi\u00e3o M.P.D.; Giorgio S.; Dolder M.A.H.; Joazeiro P.P.; Allegretti S.M.; Effectiveness of hyperbaric oxygen for experimental treatment of Schistosomiasis mansoni using praziquantel-free and encapsulated into liposomes: Assay in adult worms and oviposition. Acta Trop  2015,150,182-189","journal-title":"Acta Trop"},{"key":"ref=158","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3967\/bes2016.104","volume":"29","author":"Dkhil M.A.","year":"2016","unstructured":"Dkhil M.A.; Khalil M.F.; Bauomy A.A.; Diab M.S.; Al-Quraishy S.; Efficacy of gold nanoparticles against nephrotoxicity induced by Schistosoma mansoni infection in mice. Biomed Environ Sci  2016,29(11),773-781","journal-title":"Biomed Environ Sci"},{"key":"ref=159","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/s13071-019-3563-z","volume":"12","author":"Radwan A.","year":"2019","unstructured":"Radwan A.; El-Lakkany N.M.; William S.; El-Feky G.S.; Al-Shorbagy M.Y.; Saleh S.; Botros S.; A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection. Parasit Vectors  2019,12(1),304","journal-title":"Parasit Vectors"},{"key":"ref=160","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.2147\/IJN.S167285","volume":"13","author":"Amara R.","year":"2018","unstructured":"Amara R.; Ramadan A.; El-Moslemany R.; Eissa M.; El-Azzouni M.; El-Khordagui L.; Praziquantel-lipid nanocapsules: An oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting. Int J Nanomedicine  2018,13,4493-4505","journal-title":"Int J Nanomedicine"},{"key":"ref=161","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.nano.2016.09.010","volume":"13","author":"Marques J.","year":"2017","unstructured":"Marques J.; Valle-Delgado J.J.; Urban P.; Baro E.; Prohens R.; Mayor A.; Adaptation of targeted nanocarriers to changing requirements in antimalarial drug delivery. Nanomedicine  2017,13(2),515-525","journal-title":"Nanomedicine"},{"key":"ref=162","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1007\/s12010-014-1084-y","volume":"174","author":"Jain V.","year":"2014","unstructured":"Jain V.; Gupta A.; Pawar V.K.; Asthana S.; Jaiswal A.K.; Dube A.; Chourasia M.K.; Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles. Appl Biochem Biotechnol  2014,174(4),1309-1330","journal-title":"Appl Biochem Biotechnol"},{"key":"ref=163","doi-asserted-by":"crossref","first-page":"439389","DOI":"10.1155\/2009\/439389","volume":"2009","author":"Arruebo M.","year":"2009","unstructured":"Arruebo M.; Valladares M.; Gonz\u00e1lez-Fern\u00e1ndez A.; Antibody-conjugated nanoparticles for biomedical applications. J Nanomater  2009,2009,439389","journal-title":"J Nanomater"},{"key":"ref=164","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1039\/C7SC02747H","volume":"9","author":"Greene M.K.","year":"2018","unstructured":"Greene M.K.; Richards D.A.; Nogueira J.C.F.; Campbell K.; Smyth P.; Fern\u00e1ndez M.; Scott C.J.; Chudasama V.; Forming next-generation antibody-nanoparticle conjugates through the oriented installation of non-engineered antibody fragments. Chem Sci  2018,9(1),79-87","journal-title":"Chem Sci"},{"key":"ref=165","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/ph9040069","volume":"9","author":"Catuogno S.","year":"2016","unstructured":"Catuogno S.; Esposito C.L.; de Franciscis V.; Aptamer-mediated targeted delivery of therapeutics: An update. Pharmaceuticals  2016,9(4),69","journal-title":"Pharmaceuticals"},{"key":"ref=166","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1568026615666150413153143","volume":"15","author":"Reverdatto S.","year":"2015","unstructured":"Reverdatto S.; Burz D.S.; Shekhtman A.; Peptide aptamers: Development and applications. Curr Top Med Chem  2015,15(1082),101","journal-title":"Curr Top Med Chem"},{"key":"ref=167","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/CBO9780511546440.009","author":"Mansour J.","year":"2002","unstructured":"Mansour J.; Mansour T.E.;  Chemotherapeutic Targets in Parasites  2002,189-214","journal-title":"Chemotherapeutic Targets in Parasites"},{"key":"ref=168","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1016\/j.bbagen.2016.03.036","volume":"1861","author":"El Ridi R.","year":"2017","unstructured":"El Ridi R.; Tallima H.; Migliardo F.; Biochemical and biophysical methodologies open the road for effective schistosomiasis therapy and vaccination. Biochim Biophys Acta, Gen Subj  2017,1861(1),3613-3620","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=169","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1186\/s12864-015-2144-6","volume":"16","author":"Cabezas-Cruz A.","year":"2015","unstructured":"Cabezas-Cruz A.; Valdes J.J.; Lancelot J.; Pierce R.J.; Fast evolutionary rates associated with functional loss in class I glucose transporters of Schistosoma mansoni. BMC Genomics  2015,16(1),980","journal-title":"BMC Genomics"},{"key":"ref=170","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrm3667","volume":"14","author":"Roberts A.J.","year":"2013","unstructured":"Roberts A.J.; Kon T.; Knight P.J.; Sutoh K.; Burgess S.A.; Functions and mechanics of dynein motor proteins. Nat Rev Mol Cell Biol  2013,14(11),713-726","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=171","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.exppara.2008.10.007","volume":"121","author":"Githui E.K.","year":"2009","unstructured":"Githui E.K.; Damian R.T.; Aman R.A.; Ali M.A.; Kamau J.M.; Schistosoma spp.: Isolation of microtubule associated proteins in the tegument and the definition of dynein light chains components. Exp Parasitol  2009,121(1),96-104","journal-title":"Exp Parasitol"},{"key":"ref=172","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1096\/fj.09-130757","volume":"23","author":"Faghiri Z.","year":"2009","unstructured":"Faghiri Z.; Skelly P.J.; The role of tegumental aquaporin from the human parasitic worm, Schistosoma monsoni, in osmoregulation and drug uptake. FASEB J  2009,23(8),2780-2789","journal-title":"FASEB J"},{"key":"ref=173","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1590\/S0074-02762006000900032","volume":"101","author":"Braschi S.","year":"2006","unstructured":"Braschi S.; Borges W.C.; Wilson R.A.; Proteomic analysis of the shistosome tegument and its surface membranes. Mem Inst Oswaldo Cruz  2006,101(Suppl. 1),205-212","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref=174","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ijpara.2015.03.004","volume":"45","author":"Sotillo J.","year":"2015","unstructured":"Sotillo J.; Pearson M.; Becker L.; Mulvenna J.; Loukas A.; A quantitative proteomic analysis of the tegumental proteins from Schistosoma mansoni schistosomula reveals novel potential therapeutic targets. Int J Parasitol  2015,45(8),505-516","journal-title":"Int J Parasitol"},{"key":"ref=175","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1152\/physrev.00015.2008","volume":"89","author":"Albuquerque E.X.","year":"2009","unstructured":"Albuquerque E.X.; Pereira E.F.; Alkondon M.; Rogers S.W.; Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev  2009,89(1),73-120","journal-title":"Physiol Rev"},{"key":"ref=176","doi-asserted-by":"publisher","first-page":"e1004181","DOI":"10.1371\/journal.ppat.1004181","volume":"10","author":"MacDonald K.","year":"2014","unstructured":"MacDonald K.; Buxton S.; Kimber M.J.; Day T.A.; Robertson A.P.; Ribeiro P.; Functional characterization of a novel family of acetylcholine-gated chloride channels in Schistosoma mansoni. PLoS Pathog  2014,10(6),e1004181","journal-title":"PLoS Pathog"},{"key":"ref=177","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s13071-020-04346-1","volume":"13","author":"Eissa M.M.","year":"2020","unstructured":"Eissa M.M.; El-Azzouni M.Z.; El-Khordagui L.K.; Abdel Bary A.; El-Moslemany R.M.; Abdel Salam S.A.; Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental Schistosomiasis mansoni. Parasit Vectors  2020,13(1),474","journal-title":"Parasit Vectors"},{"key":"ref=178","doi-asserted-by":"publisher","first-page":"e0009423","DOI":"10.1371\/journal.pntd.0009423","volume":"15","author":"Abd El Wahab W.M.","year":"2021","unstructured":"Abd El Wahab W.M.; El-Badry A.A.; Mahmoud S.S.; El-Badry Y.A.; El-Badry M.A.; Hamdy D.A.; Ginger (Zingiber Officinale)-derived nanoparticles in Schistosoma mansoni infected mice: Hepatoprotective and enhancer of etiological treatment. PLoS Negl Trop Dis  2021,15(5),e0009423","journal-title":"PLoS Negl Trop Dis"},{"key":"ref=179","doi-asserted-by":"publisher","first-page":"195101","DOI":"10.1088\/1361-6528\/ab6d9c","volume":"31","author":"Obeid M.A.","year":"2020","unstructured":"Obeid M.A.; Gany S.A.S.; Gray A.I.; Young L.; Igoli J.O.; Ferro V.A.; Niosome-encapsulated balanocarpol: Compound isolation, characterisation, and cytotoxicity evaluation against human breast and ovarian cancer cell lines. Nanotechnology  2020,31(19),195101","journal-title":"Nanotechnology"},{"key":"ref=180","doi-asserted-by":"publisher","first-page":"748","DOI":"10.2174\/2210681209666190807145229","volume":"10","author":"Aljabali A.A.A.","year":"2020","unstructured":"Aljabali A.A.A.; Obeid M.A.; Inorganic-organic nanomaterials for therapeutics and molecular imaging applications. Nanosci Nanotechnol Asia  2020,10(6),748-765","journal-title":"Nanosci Nanotechnol Asia"},{"key":"ref=181","doi-asserted-by":"publisher","first-page":"2532","DOI":"10.1021\/acssensors.8b00759","volume":"3","author":"Welearegay T.G.","year":"2018","unstructured":"Welearegay T.G.; Diouani M.F.; \u00d6sterlund L.; Ionescu F.; Belgacem K.; Smadhi H.; Khaled S.; Kidar A.; Cindemir U.; Laouini D.; Ionescu R.; Ligand-capped ultrapure metal nanoparticle sensors for the detection of cutaneous leishmaniasis disease in exhaled breath. ACS Sens  2018,3(12),2532-2540","journal-title":"ACS Sens"},{"key":"ref=182","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1080\/08982104.2020.1768110","volume":"31","author":"Obeid M.A.","year":"2021","unstructured":"Obeid M.A.; Teeravatcharoenchai T.; Connell D.; Niwasabutra K.; Hussain M.; Carter K.; Ferro V.A.; Examination of the effect of niosome preparation methods in encapsulating model antigens on the vesicle characteristics and their ability to induce immune responses. J Liposome Res  2021,31(2),195-202","journal-title":"J Liposome Res"},{"key":"ref=183","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-981-15-4802-4_7","author":"Aljabali A.A.","year":"2020","unstructured":"Aljabali A.A.; Obeid M.A.; Amawi H.A.; Rezigue M.M.; Hamzat Y.; Satija S.;  Applications of Nanomaterials in Human Health  2020,125-146","journal-title":"Applications of Nanomaterials in Human Health"},{"key":"ref=184","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1166\/jbn.2018.2517","volume":"14","author":"Wu Y.","year":"2018","unstructured":"Wu Y.; Liu J.; Lin Y.; Weng R.; Chen R.; Li J.; Lv Z.; Diagnosis, monitoring, and control of schistosomiasis-An update. J Biomed Nanotechnol  2018,14(3),430-455","journal-title":"J Biomed Nanotechnol"},{"key":"ref=185","first-page":"83","volume":"117","author":"Feng Z.Q.","year":"2004","unstructured":"Feng Z.Q.; Zhong S.G.; Li Y.H.; Li Y.Q.; Qiu Z.N.; Wang Z.M.; Li J.; Dong L.; Guan X.H.; Nanoparticles as a vaccine adjuvant of anti-idiotypic antibody against schistosomiasis. Chin Med J (Engl)  2004,117(1),83-87","journal-title":"Chin Med J (Engl)"},{"key":"ref=186","doi-asserted-by":"publisher","first-page":"219","DOI":"10.21608\/aimj.2020.21461.1031","volume":"1","author":"Aly I.","year":"2020","unstructured":"Aly I.; Efficacy of iron oxide nanoparticles in diagnosis of schistosomiasis. Al-Azhar Int Med J  2020,1(2),219-224","journal-title":"Al-Azhar Int Med J"},{"key":"ref=187","first-page":"977","volume":"7","author":"Aly I.","year":"2014","unstructured":"Aly I.; Zalat R.; El Aswad B.E.D.W.; Moharm I.M.; Masoud B.M.; Novel nanomagnetic beads based-latex agglutination assay for rapid diagnosis of human schistosomiasis haematobium. Biomed Opt Express  2014,7(12),977-983","journal-title":"Biomed Opt Express"},{"key":"ref=188","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.actatropica.2017.09.024","volume":"177","author":"Aly I.","year":"2018","unstructured":"Aly I.; Taher E.E.; EL nain, G.; EL Sayed, H.; Mohammed, F.A.; Hamad, R.S.; Bayoumy, E.M. Advantages of bioconjugated silica-coated nanoparticles as an innovative diagnosis for human toxoplasmosis. Acta Trop  2018,177,19-24","journal-title":"Acta Trop"},{"key":"ref=189","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1039\/b918880k","volume":"135","author":"Sharma M.K.","year":"2010","unstructured":"Sharma M.K.; Agarwal G.S.; Rao V.K.; Upadhyay S.; Merwyn S.; Gopalan N.; Rai G.P.; Vijayaraghavan R.; Prakash S.; Amperometric immunosensor based on gold nanoparticles\/alumina sol-gel modified screen-printed electrodes for antibodies to Plasmodium falciparum histidine rich protein-2. Analyst  2010,135(3),608-614","journal-title":"Analyst"},{"key":"ref=190","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00216-011-5489-y","volume":"402","author":"Guirgis B.S.S.","year":"2012","unstructured":"Guirgis B.S.S.; S\u00e1 e Cunha C.; Gomes I.; Cavadas M.; Silva I.; Doria G.; Blatch G.L.; Baptista P.V.; Pereira E.; Azzazy H.M.E.; Mota M.M.; Prud\u00eancio M.; Franco R.; Gold nanoparticle-based fluorescence immunoassay for malaria antigen detection. Anal Bioanal Chem  2012,402(3),1019-1027","journal-title":"Anal Bioanal Chem"},{"key":"ref=191","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ab.2013.03.032","volume":"439","author":"Jeon W.","year":"2013","unstructured":"Jeon W.; Lee S.; Dh M.; Ban C.; A colorimetric aptasensor for the diagnosis of malaria based on cationic polymers and gold nanoparticles. Anal Biochem  2013,439(1),11-16","journal-title":"Anal Biochem"},{"key":"ref=192","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/bios11050134","volume":"11","author":"Safarpour H.","year":"2021","unstructured":"Safarpour H.; Majdi H.; Masjedi A.; Pagheh A.S.; Pereira M.L.; Rodrigues Oliveira S.M.; Ahmadpour E.; Development of optical biosensor using protein a-conjugated chitosan-gold nanoparticles for diagnosis of cystic echinococcosis. Biosensors  2021,11(5),134","journal-title":"Biosensors"},{"key":"ref=193","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.mimet.2013.10.011","volume":"96","author":"Andreadou M.","year":"2014","unstructured":"Andreadou M.; Liandris E.; Gazouli M.; Taka S.; Antoniou M.; Theodoropoulos G.; Tachtsidis I.; Goutas N.; Vlachodimitropoulos D.; Kasampalidis I.; Ikonomopoulos J.; A novel non-amplification assay for the detection of Leishmania spp. in clinical samples using gold nanoparticles. J Microbiol Methods  2014,96,56-61","journal-title":"J Microbiol Methods"},{"key":"ref=194","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.colsurfb.2012.07.021","volume":"101","author":"Jiang S.","year":"2013","unstructured":"Jiang S.; Hua E.; Liang M.; Liu B.; Xie G.; A novel immunosensor for detecting toxoplasma gondii-specific IgM based on goldmag nanoparticles and graphene sheets. Colloids Surf B Biointerfaces  2013,101,481-486","journal-title":"Colloids Surf B Biointerfaces"}],"container-title":["Current Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230223085403","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/213939\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1567201820666230223085403","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T12:24:30Z","timestamp":1715257470000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/213939\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":194,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567201820666230223085403","relation":{},"ISSN":["1567-2018"],"issn-type":[{"value":"1567-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-06-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}